Understanding how lung immune cells help repair lung injuries
CREB Programming of Alveolar Macrophage Population and Inflammatory Lung Injury
This study is looking at how certain immune cells in the lungs can help heal severe lung injuries, and it aims to find ways to boost these cells' ability to promote recovery, which could lead to better treatments for lung problems caused by infections or inflammation.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10895348 on NIH RePORTER |
What this research studies
This research investigates the role of alveolar macrophages, a type of immune cell in the lungs, in promoting recovery from severe lung injuries. The study focuses on how these cells can be mobilized and regulated, particularly through a transcription factor known as CREB. By examining the mechanisms that lead to the generation of reparative macrophages, the research aims to uncover new insights into lung repair processes. This could lead to better strategies for treating lung injuries caused by infections or other inflammatory conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a history of lung injury or inflammatory lung conditions.
Not a fit: Patients with stable lung conditions or those not experiencing any lung-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for patients suffering from lung injuries and inflammatory diseases.
How similar studies have performed: Previous research has shown promising results in understanding macrophage functions in lung repair, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Mehta, Dolly — University of Illinois at Chicago
- Study coordinator: Mehta, Dolly
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.